SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）

Abroad (travel likely)RecruitingPHASE2

Conditions

Unresectable Locally Recurrent Rectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Contact: Study coordinator (Jun Hu) · zslyllb@mail.sysu.edu.cn · +86-020-38379764

Study leads

Jun Huang, MD
Principal Investigator
Sun Yat-sen University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer

Unresectable Locally Recurrent Rectal Cancer

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Solid Tumor, Adult · Colorectal Cancer · NSCLC

Abroad (travel likely)RecruitingPHASE1, PHASE2

Gilbert, United States · La Jolla, United States

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Solid Tumor, Adult · Colorectal Cancer · Non-Small Cell Lung

Abroad (travel likely)RecruitingPHASE1, PHASE2

Gilbert, United States · La Jolla, United States